You have free access to this content

Arthritis Care & Research

Cover image for Arthritis Care & Research

15 May 2009

Volume 61, Issue 5

Pages 559–714

Currently known as: Arthritis Care & Research

  1. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
  2. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis (pages 560–568)

      Sophie Martin Du Pan, Silvia Dehler, Adrian Ciurea, Hans-Rudolf Ziswiler, Cem Gabay and Axel Finckh

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24463

      • original image
      • original image
      • original image
  3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: Results from a randomized control study (pages 569–576)

      Roman Krzysiek, Maxime Breban, Philippe Ravaud, Maria Vittoria Prejean, John Wijdenes, Carine Roy, Yves-Dominique Henry, Carole Barbey, Gérard Trappe, Maxime Dougados and Dominique Emilie

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24275

      • original image
      • original image
    2. You have free access to this content
      Treatment of relapsing polychondritis with rituximab: A retrospective study of nine patients (pages 577–582)

      Gaëlle Leroux, Nathalie Costedoat-Chalumeau, Benoît Brihaye, Judith Cohen-Bittan, Zahir Amoura, Julien Haroche, Nicolas Limal, Olivier Bletry and Jean-Charles Piette

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24366

  4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
    2. You have free access to this content
      Biologic therapy and pregnancy outcomes in women with rheumatic diseases (pages 587–592)

      Evelyne Vinet, Christian Pineau, Caroline Gordon, Ann E. Clarke and Sasha Bernatsky

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24462

      • original image
    3. You have free access to this content
  5. Behcet's Disease

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Epidemiology and clinical characteristics of behçet's disease in the US: A population-based study (pages 600–604)

      Kenneth T. Calamia, Floranne C. Wilson, Murat Icen, Cynthia S. Crowson, Sherine E. Gabriel and Hilal Maradit Kremers

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24423

  6. Disability

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Differences in the workforce experiences of women and men with arthritis disability: A population health perspective (pages 605–613)

      Simone A. Kaptein, Monique A. M. Gignac and Elizabeth M. Badley

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24427

    2. You have free access to this content
      Problems experienced by people with arthritis when using a computer (pages 614–622)

      Nancy A. Baker, Joan C. Rogers, Elaine N. Rubinstein, Saralynn H. Allaire and Mary Chester Wasko

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24465

      • original image
      • original image
      • original image
  7. Measurement

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Measuring shoulder function: A systematic review of four questionnaires (pages 623–632)

      Jean-Sébastien Roy, Joy C. MacDermid and Linda J. Woodhouse

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24396

      • original image
  8. Osteoarthritis

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
  9. Disability

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      The high prevalence of knee osteoarthritis in a rural Chinese population: The Wuchuan osteoarthritis study (pages 641–647)

      Xiaozheng Kang, Marlene Fransen, Yuqing Zhang, Hu Li, Yan Ke, Ming Lu, Steve Su, Xiongying Song, Yong Guo, Jie Chen, Jingbo Niu, David Felson and Jianhao Lin

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24464

      • original image
  10. Osteoarthritis

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Medial opening wedge high tibial osteotomy: A prospective cohort study of gait, radiographic, and patient-reported outcomes (pages 648–657)

      Trevor B. Birmingham, J. Robert Giffin, Bert M. Chesworth, Dianne M. Bryant, Robert B. Litchfield, Kevin Willits, Thomas R. Jenkyn and Peter J. Fowler

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24466

      • original image
      • original image
  11. Pediatric Rheumatology

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Development and validation of a composite disease activity score for juvenile idiopathic arthritis (pages 658–666)

      Alessandro Consolaro, Nicolino Ruperto, Anna Bazso, Angela Pistorio, Silvia Magni-Manzoni, Giovanni Filocamo, Clara Malattia, Stefania Viola, Alberto Martini and Angelo Ravelli

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24516

      • original image
  12. Rheumatoid Arthritis

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
  13. Retroperitoneal Fibrosis

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? (pages 674–679)

      Marina N. Magrey, M. Elaine Husni, Irving Kushner and Leonard H. Calabrese

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24461

      • original image
      • original image
      • original image
  14. Systemic Lupus Erythematosus

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Cognitive impairment and employment status in systemic lupus erythematosus: A prospective longitudinal study (pages 680–687)

      Simone Appenzeller, Fernando Cendes and Lilian T. L. Costallat

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24346

  15. Systemic Sclerosis

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients (pages 688–694)

      M. Sebastiani, A. Manfredi, M. Colaci, R. D'amico, V. Malagoli, D. Giuggioli and C. Ferri

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24394

      • original image
      • original image
    2. You have free access to this content
      Validation of a manual ability questionnaire in patients with systemic sclerosis (pages 695–703)

      Marie Vanthuyne, Vanessa Smith, Seher Arat, René Westhovens, Filip de Keyser, Frédéric A. Houssiau, Jean-Louis Thonnard and Laure Vandervelde

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24426

      • original image
      • original image
      • original image
  16. Contributions from the Field

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
    2. You have free access to this content
      An early view of the international Sjögren's syndrome registry (pages 711–714)

      Troy E. Daniels, Lindsey A. Criswell, Caroline Shiboski, Stephen Shiboski, Hector Lanfranchi, Yi Dong, Morten Schiødt, Hisanori Umehara, Susumu Sugai, Stephen Challacombe and John S. Greenspan

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24397

      • original image
  17. Submissions Invited

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
  18. Announcements

    1. Top of page
    2. Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    3. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    4. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases–The First Decade
    5. Special Articles: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    6. Behcet's Disease
    7. Disability
    8. Measurement
    9. Osteoarthritis
    10. Disability
    11. Osteoarthritis
    12. Pediatric Rheumatology
    13. Rheumatoid Arthritis
    14. Retroperitoneal Fibrosis
    15. Systemic Lupus Erythematosus
    16. Systemic Sclerosis
    17. Contributions from the Field
    18. Submissions Invited
    19. Announcements
    1. You have free access to this content
      ARHP announcements

      Version of Record online: 29 APR 2009 | DOI: 10.1002/art.24652

SEARCH

SEARCH BY CITATION